Treatment of spastic movement disorders during childhood with botulinum toxin A;Die therapie spastischer bewegungsstörungen im kindesalter mit botulinumtoxin A

Klinische Neurophysiologie

Volumn 32, Issue 4, 2001, Pages 218-224

  Mall, V ^a   Berweck, S ^b   Kirschner, J ^a   Herrmann, J ^a   Schelle, A ^a   Linder, M ^a   Michaelis, U ^a   Stein, S ^a   Korinthenberg, R ^a   Heinen, F ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Klinikum Duisburg   (Germany)

Author keywords

Botulinum Toxin A; Cerebralparese; Spastic Movement Disorders Evaluation

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; PLACEBO;

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; ELECTROMYOGRAPHY; GASTROCNEMIUS MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; OUTCOMES RESEARCH; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035662333     PISSN: 14340275     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18957     Document Type: Article

References (37)

1. Preliminary trial of carisoprodol in multiple sclerosis
2. Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia
3. Atypical presentations of doparesponsive dystonia
4. Analgesic effects of botulinum toxin A: A randomized, placebocontrolled clinical trial
5. Interrater reliability of a modified ashworth scale of muscle spasticity
6. Dopa responsive dystonia: A treatable condition misdiagnosed as cerebral palsy
7. Orofaciomandibular and lingual dystonia (Meige Syndrome)
8. Evaluating research in developmental disabilities: A conceptual framework for reviewing treatment outcomes
9. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial
10. Botulinum toxin A in the hemiplegic upper limb: A double-blind trial
11. The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response
12. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy
13. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy
14. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy
15. Controlled trials of botulinum toxin for cervical dystonia: A critical review
16. The origins of cerebral palsy
17. Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A - The parents' view of functional outcome
18. Torticollis spasmodicus
19. Lack of response to botulinum toxin A in patients with hypertrophic pyloric stenosis
20. Botulinum-Toxin A: Neue möglichkeiten in der behandlung spastischer bewegungsstörungen
21. Interventional neuropediatrics: Treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A
22. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial
23. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial
24. Bilateral spastic cerebral palsy - A comparative study between south-west Germany and western Sweden. I: Clinical patterns and disabilities
25. Bilateral spastic cerebral palsy - A comparative study between southwest Germany and western Sweden. II: Epidemiology
26. Treatment of Neuropathic Bladder using Botulinum Toxin A in a one year-old Child with Myelomeningocele
27. Botulinum toxin type A treatment of cerebral palsy: An integrated approach
28. Dopa-responsive dystonia simulating cerebral palsy
29. Goal attainment scaling as a measure of change in infants with motor delays
30. Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions
31. Evaluating motor function in children with Down syndrome: Validity of the GMFM
32. Improved scaling of the gross motor function measure for children with cerebral palsy: Evidence of reliability and validity
33. Locomotor development in children with cerebral palsy
34. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy
35. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
36. 125i-labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection